The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

OVID FINANCIAL STATEMENTS

Ovid Therapeutics Inc — balance sheet, income statement and cash flow trends

OVIDOvid Therapeutics Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-250 M0250 M202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue1.6 M $Gross Profit1.5 M $ · 98%Operating Income-58.4 M $ · -3687%Pre-tax Income-34.5 M $ · -2179%Net Income to Owners-34.5 M $ · -2179%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue1.6 M $-76.2%
Gross Profit1.5 M $-76.7%
Operating Income-58.4 M $—
EBITDA-35.8 M $—
Net Income to Owners-34.5 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0100 M200 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets232 M
  • Equity209.9 M $90%
  • Current Liabilities10 M $4%
  • Long-term Liabilities12.1 M $5%

Key Figures

YoY change
Total Assets232 M $+199.6%
Total Liabilities22.1 M $+2.1%
Total Equity209.9 M $+276.2%
Cash & ST Investments117.2 M $+205.7%
Total Debt12.7 M $-9.8%
Net Debt1.4 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
0100 M202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-200 M-100 M0-54.8 M $Operating-147.8 M $Investing185.8 M $Financing-16.8 M $Net Change

Key Figures

YoY change
Operating Cash Flow-54.8 M $—
Capital Expenditures0 $-100.0%
Free Cash Flow-54.8 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on OVID

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 2, 26. This content is for informational purposes only and is not investment advice.